DiaMedica Therapeutics Inc. | Business Contracts

Employment Agreement effective as of January 3, 2022 between DiaMedica USA, Inc. and Kirsten Gruis (Filed With SEC on March 28, 2023)

Lease Guaranty Agreement dated June 22, 2022 by DiaMedica Therapeutics Inc (Filed With SEC on June 29, 2022)

Form of Registration Rights Agreement by and among DiaMedica Therapeutics Inc. and the purchasers party thereto (Filed With SEC on September 27, 2021)

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 10, 2021)

Second Amendment to GPEx Development and Manufacturing Agreement dated as of October 22, 2018 between DiaMedica Therapeutics Inc. and Catalent Pharma Solutions, LLC (Filed With SEC on March 23, 2020)

301 Carlson Parkway Office Lease dated June 22, 2022 between Medica Services Company, LLC and DiaMedica USA Inc (Filed With SEC on June 29, 2022)

Consulting Services Agreement dated as of May 23, 2022 by and between Harry Alcorn, Jr. Pharm.D. and DiaMedica USA, Inc (Filed With SEC on May 25, 2022)

Separation Agreement and Release dated as of May 23, 2022 by and between Harry Alcorn, Jr. Pharm.D. and DiaMedica USA, Inc (Filed With SEC on May 25, 2022)

DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan (Filed With SEC on May 19, 2022)

Form of Inducement Option Award Agreement under the DiaMedica Therapeutics Inc. 2021 Employment Incentive Plan (Filed With SEC on March 14, 2022)

DiaMedica Therapeutics Inc. 2021 Employment Inducement Incentive Plan (Filed With SEC on March 14, 2022)

Form of Option Award Agreement under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan (Filed With SEC on March 14, 2022)

Securities Purchase Agreement, dated as of September 26, 2021, by and among DiaMedica Therapeutics Inc. and the purchasers party thereto (Filed With SEC on September 27, 2021)

Warrant dated September 11, 2020 issued by DiaMedica Therapeutics Inc. to Craig-Hallum Capital Group LLC (Filed With SEC on November 4, 2020)

Form of Deferred Stock Unit Award Agreement under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan (Filed With SEC on August 11, 2020)

Underwriting Agreement, dated August 6, 2020, by and between DiaMedica Therapeutics Inc. and Guggenheim Securities, LLC (Filed With SEC on August 10, 2020)

Warrant dated October 1, 2019 issued by DiaMedica Therapeutics Inc. to Craig-Hallum Capital Group LLC (Filed With SEC on March 23, 2020)

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 23, 2020)

Underwriting Agreement, dated February 11, 2020, by and between DiaMedica Therapeutics Inc. and Craig-Hallum Capital Group LLC (Filed With SEC on February 13, 2020)

Litigation Funding Agreement, dated as of December 27, 2019, between LEGALIST FUND II, L.P. and DiaMedica Therapeutics Inc (Filed With SEC on January 3, 2020)

Form of Restricted Stock Unit Award Agreement under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan (Filed With SEC on June 21, 2019)

Form of Option Award Agreement under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan (Filed With SEC on June 21, 2019)

DiaMedica Therapeutics Inc. Short-Term Incentive Plan (Filed With SEC on June 21, 2019)

Form of Indemnification Agreement between DiaMedica Therapeutics Inc. and each Director and Officer (Filed With SEC on June 4, 2019)

Specimen Certificate representing Voting Common Shares of DiaMedica Therapeutics Inc (Filed With SEC on June 4, 2019)

DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan (Filed With SEC on May 23, 2019)

Employment Agreement by and between DiaMedica Therapeutics Inc. and Harry Alcorn, Ph.D (Filed With SEC on March 19, 2019)

Employment Agreement by and between DiaMedica Therapeutics Inc. and Scott Kellen (Filed With SEC on March 19, 2019)

DiaMedica Therapeutics Inc. (28)